Response to "Are roots really not worth considering?"

被引：0

作者：

Guckenberger, M. ^{[1
]}

Guninski, R. S. ^{[1
]}

Andratschke, N. ^{[1
]}

Belka, C. ^{[2
,3
,4
]}

Bellut, D. ^{[5
]}

Cuccia, F. ^{[6
]}

Dahele, M. ^{[7
,8
]}

Josipovic, M. ^{[9
,10
]}

Mancosu, P. ^{[11
]}

Minniti, G. ^{[12
,13
]}

Niyazi, M. ^{[14
]}

Ricardi, U. ^{[15
]}

Rosenschold, P. Munck Af ^{[16
]}

Sahgal, A. ^{[17
]}

Tsang, Y. ^{[18
]}

Verbakel, W. ^{[19
]}

Alongi, F. ^{[20
,21
]}

机构：

[1] Univ Zurich, Univ Hosp Zurich, Dept Radiat Oncol, Zurich, Switzerland

[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiat Oncol, Munich, Germany

[3] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany

[4] Bavarian Canc Res Ctr BZKF, Munich, Germany

[5] Univ Zurich, Univ Hosp Zurich, Dept Neurosurg, Zurich, Switzerland

[6] ARNAS Civ Hosp, Radiat Oncol Unit, Palermo, Italy

[7] Vrije Univ Amsterdam, Dept Radiat Oncol, Amsterdam UMC Locat, Boelelaan 1117, Amsterdam, Netherlands

[8] Canc Ctr Amsterdam, Boelelaan 1117, Amsterdam, Netherlands

[9] Copenhagen Univ Hosp, Rigshosp, Ctr Canc & Organ Dis, Dept Oncol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark

[10] Univ Copenhagen, Dept Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark

[11] IRCCS Humanitas Res Hosp, Radiat Oncol Dept, Med Phys Unit, via Manzoni 56, I-20089 Milan, Italy

[12] Sapienza Univ Rome, Dept Radiol Sci Oncol & Anat Pathol, Rome, Italy

[13] IRCCS Neuromed, Pozzilli, IS, Italy

[14] Univ Hosp Tubingen, Dept Radiat Oncol, Tubingen, Germany

[15] Univ Turin, Dept Oncol, Turin, Italy

[16] Rigshospitalet, Radiat Med Res Ctr, Copenhagen, Denmark

[17] Odette Canc Ctr Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol, Toronto, ON, Canada

[18] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada

[19] Univ Amsterdam, Dept Radiat Oncol, Med Ctr, Amsterdam, Netherlands

[20] IRCCS Osped Sacro Cuore Don Calabria, Adv Radiat Dept, Verona, Italy

[21] Univ Brescia, Brescia, Italy

来源：

RADIOTHERAPY AND ONCOLOGY | 2024年 / 199卷

关键词：

BODY RADIATION-THERAPY; METASTASES; PHASE-2;

D O I：

10.1016/j.radonc.2024.110431

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 10 条

[1] Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence
Bishop, Andrew J.
Tao, Randa
Rebueno, Neal C.
Christensen, Eva N.
Allen, Pamela K.
Wang, Xin A.
Amini, Behrang
Tannir, Nizar M.
Tatsui, Claudio E.
Rhines, Laurence D.
Li, Jing
Chang, Eric L.
Brown, Paul D.
Ghia, Amol J.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (05): : 1016 - 1026
[2] ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases
Guckenberger, M.
Andratschke, N.
Belka, C.
Bellut, D.
Cuccia, F.
Dahele, M.
Guninski, R. S.
Josipovic, M.
Mancosu, P.
Minniti, G.
Niyazi, M.
Ricardi, U.
Munck, P.
Sahgal, A.
Tsang, Y.
Verbakel, W. F. A. R.
Alongi, F.
[J]. RADIOTHERAPY AND ONCOLOGY, 2024, 190
[3] Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial
Guckenberger, Matthias
Billiet, Charlotte
Schnell, Daniel
Franzese, Ciro
Spalek, Mateusz
Rogers, Susanne
Stelmes, Jean-Jacques
Aebersold, Daniel M.
Hemmatazad, Hossein
Zimmermann, Frank
Zimmer, Joerg
Zilli, Thomas
Bruni, Alessio
Baumert, Brigitta G.
Naegler, Franziska
Gut, Philipp
Forster, Robert
Madani, Indira
[J]. CANCER, 2024, 130 (15) : 2713 - 2722
[4] Assessment of minimum target dose as a predictor of local failure after spine SBRT
Kowalchuk, Roman O.
Mullikin, Trey C.
Spears, Grant M.
Johnson-Tesch, Benjamin A.
Rose, Peter S.
Siontis, Brittany L.
Kim, Dong Kun
Costello, Brian A.
Morris, Jonathan M.
Gao, Robert W.
Shiraishi, Satomi
Lucido, John J.
Olivier, Kenneth R.
Owen, Dawn
Stish, Bradley J.
Waddle, Mark R.
Laack, Nadia N.
Park, Sean S.
Brown, Paul D.
Merrell, Kenneth W.
[J]. RADIOTHERAPY AND ONCOLOGY, 2024, 195
[5] Milano MT, 2023, Int J Radiat Oncol
[6] Pielkenrood BJ, 2021, INT J RADIAT ONCOL, V110, P358, DOI 10.1016/j.ijrobp.2020.11.060
[7] Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial
Sahgal, Arjun
Myrehaug, Sten D.
Siva, Shankar
Masucci, Giuseppina L.
Maralani, Pejman J.
Brundage, Michael
Butler, James
Chow, Edward
Fehlings, Michael G.
Foote, Mathew
Gabos, Zsolt
Greenspoon, Jeffrey
Kerba, Marc
Lee, Young
Liu, Mitchell
Liu, Stanley K.
Thibault, Isabelle
Wong, Rebecca K.
Hum, Maaike
Ding, Keyue
Parulekar, Wendy R.
[J]. LANCET ONCOLOGY, 2021, 22 (07) : 1023 - 1033
[8] Sari SY, In regard to Guckenberger
[9] A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
Videtic, Gregory M. M.
Hu, Chen
Singh, Anurag K.
Chang, Joe Y.
Parker, William
Olivier, Kenneth R.
Schild, Steven E.
Komaki, Ritsuko
Urbanic, James J.
Choy, Hak
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (04): : 757 - 764
[10] The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery
Yamada, Yoshiya
Katsoulakis, Evangelia
Laufer, Ilya
Lovelock, Michael
Barzilai, Ori
McLaughlin, Lily A.
Zhang, Zhigang
Schmitt, Adam M.
Higginson, Daniel S.
Lis, Eric
Zelefsky, Michael J.
Mechalakos, James
Bilsky, Mark H.
[J]. NEUROSURGICAL FOCUS, 2017, 42 (01)

← 1 →